Mirko Pinotti Selected Research

U1 small nuclear RNA

11/2020	An Exon-Specific Small Nuclear U1 RNA (ExSpeU1) Improves Hepatic OTC Expression in a Splicing-Defective spf/ash Mouse Model of Ornithine Transcarbamylase Deficiency.
1/2019	Rescue of spinal muscular atrophy mouse models with AAV9-Exon-specific U1 snRNA.
6/2012	An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mirko Pinotti Research Topics

Disease

9	Hemophilia B (Haemophilia B) 01/2022 - 06/2012
7	Hemophilia A (Haemophilia) 05/2024 - 09/2012
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 09/2004
5	Hemorrhage 01/2019 - 12/2003
5	Myocardial Infarction 10/2016 - 09/2004
4	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 07/2012
3	Neoplasms (Cancer) 08/2021 - 01/2016
3	Factor VII Deficiency (Hypoproconvertinemia) 03/2018 - 02/2002
2	Venous Thromboembolism 09/2023 - 05/2003
2	Reperfusion Injury 03/2023 - 01/2021
2	Ornithine Carbamoyltransferase Deficiency Disease 12/2021 - 11/2020
2	ST Elevation Myocardial Infarction 01/2021 - 10/2016
2	Type 2 von Willebrand Disease 01/2020 - 12/2010
2	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2019 - 06/2012
1	Shwachman-Diamond Syndrome 02/2023
1	Neurologic Manifestations (Neurological Manifestations) 04/2022
1	Epilepsy (Aura) 04/2022
1	Hepatocellular Carcinoma (Hepatoma) 12/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Tyrosinemias (Tyrosinemia) 03/2020
1	Fabry Disease (Fabry's Disease) 01/2020
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Acute-Phase Reaction 01/2019
1	Familial Dysautonomia (Riley Day Syndrome) 01/2018
1	Leukemia 01/2016
1	Cystic Fibrosis (Mucoviscidosis) 06/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2010
1	Sleep Deprivation 08/2010
1	Factor V Deficiency 03/2008
1	Factor X Deficiency 04/2004
1	Thrombophilia 05/2003

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 09/2023 - 06/2009
8	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2022 - 09/2012
5	Nonsense Codon (Nonsense Mutation)IBA 01/2022 - 09/2012
5	Factor VII (Proconvertin)IBA 03/2012 - 02/2002
4	Factor VIII (Coagulation Factor VIII)IBA 05/2024 - 12/2010
3	RNA (Ribonucleic Acid)IBA 02/2023 - 01/2019
3	NucleotidesIBA 04/2022 - 01/2019
3	U1 small nuclear RNAIBA 11/2020 - 06/2012
3	Blood Coagulation Factors (Coagulation Factor)IBA 01/2019 - 04/2010
2	DNA (Deoxyribonucleic Acid)IBA 05/2024 - 08/2021
2	CoagulantsIBA 01/2023 - 12/2010
2	Adenosine Triphosphate (ATP)IBA 01/2021 - 10/2016
2	von Willebrand FactorIBA 01/2020 - 12/2010
2	Factor VIIa (Activated Factor VII)IBA 01/2020 - 09/2004
2	Biomarkers (Surrogate Marker)IBA 10/2016 - 07/2015
2	RNA Splice SitesIBA 09/2015 - 03/2008
2	Thrombin FDA Link 08/2010 - 12/2003
2	Messenger RNA (mRNA)IBA 03/2008 - 03/2008
2	Factor V (Coagulation Factor V)IBA 03/2008 - 12/2003
1	oligomycin AIBA 03/2023
1	AntibodiesIBA 01/2023
1	Human Serum Albumin FDA LinkGeneric 01/2021
1	1- palmitoyl- 2- (10- (4- ((trifluoromethyl)diazirinyl)phenyl)- 8- oxadecanoyl)- sn- glycero- 3- phosphocholineIBA 01/2021
1	N 30IBA 01/2021
1	neonatal Fc receptorIBA 01/2021
1	fumarylacetoacetase (fumarylacetoacetate hydrolase)IBA 03/2020
1	CollagenIBA 01/2020
1	GalactosidasesIBA 01/2020
1	RistocetinIBA 01/2020
1	AntigensIBA 01/2020
1	AntithrombinsIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	EnzymesIBA 03/2018
1	ElementsIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	antibiotic G 418IBA 01/2017
1	N(2)-(3-trifluoromethylphenyl)guanineIBA 10/2016
1	Antisense OligonucleotidesIBA 01/2016
1	Factor XIII (Coagulation Factor XIII)IBA 07/2015
1	GuanineIBA 07/2012
1	Small Nuclear RNA (snRNA)IBA 06/2012
1	Genetic Markers (Genetic Marker)IBA 03/2012
1	LipidsIBA 12/2010
1	Vitamin K FDA Link 04/2010
1	AnticoagulantsIBA 04/2010
1	Protein SIBA 04/2010
1	Protein CIBA 04/2010
1	Hemostatics (Antihemorrhagics)IBA 02/2008
1	Factor X (Stuart Factor)IBA 04/2004
1	factor V LeidenIBA 12/2003
1	Fibrinogen (Factor I)FDA Link 05/2003

Therapy/Procedure

8	Therapeutics 05/2024 - 11/2014
1	Percutaneous Coronary Intervention 10/2016